A detailed history of Greenline Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Greenline Partners, LLC holds 65,041 shares of PFE stock, worth $1.88 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
65,041
Previous 69,502 6.42%
Holding current value
$1.88 Million
Previous $1.93 Million 5.65%
% of portfolio
0.28%
Previous 0.31%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $112,684 - $132,045
-4,461 Reduced 6.42%
65,041 $1.82 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $18,148 - $20,840
-701 Reduced 1.0%
69,502 $1.93 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $358,085 - $465,113
-13,704 Reduced 16.33%
70,203 $2.02 Million
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $89,274 - $104,352
-2,782 Reduced 3.21%
83,907 $2.78 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $98,715 - $114,212
-2,733 Reduced 3.06%
86,689 $3.18 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $221,489 - $288,347
-5,623 Reduced 5.92%
89,422 $3.65 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1.65 Million - $2.16 Million
-39,552 Reduced 29.39%
95,045 $4.87 Million
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $1.79 Million - $2.19 Million
-40,908 Reduced 23.31%
134,597 $5.89 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $249,912 - $296,318
5,371 Added 3.16%
175,505 $9.2 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $65,148 - $80,726
-1,424 Reduced 0.83%
170,134 $8.81 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $286,760 - $425,075
6,940 Added 4.22%
171,558 $10.1 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $667 - $857
17 Added 0.01%
164,618 $7.08 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $61,944 - $70,173
-1,725 Reduced 1.04%
164,601 $6.45 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $602,250 - $679,217
17,983 Added 12.12%
166,326 $6.03 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $2,209 - $2,808
-66 Reduced 0.04%
148,343 $5.46 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $2.47 Million - $2.9 Million
77,924 Added 110.55%
148,409 $5.45 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $15,692 - $19,037
-521 Reduced 0.73%
70,485 $2.3 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $1.14 Million - $1.62 Million
-42,043 Reduced 37.19%
71,006 $2.32 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $368,704 - $418,432
-11,200 Reduced 9.01%
113,049 $4.43 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $249,718 - $323,811
7,686 Added 6.59%
124,249 $4.46 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $23,963 - $26,904
648 Added 0.56%
116,563 $5.05 Million
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $4.46 Million - $4.9 Million
-118,867 Reduced 50.63%
115,915 $4.92 Million
Q3 2018

Oct 15, 2018

SELL
$34.47 - $41.81 $57,875 - $70,198
-1,679 Reduced 0.71%
234,782 $10.3 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $176,179 - $187,824
-5,342 Reduced 2.21%
236,461 $8.58 Million
Q1 2018

Jun 21, 2018

BUY
$31.91 - $37.02 $636,253 - $738,141
19,939 Added 8.99%
241,803 $8.58 Million
Q4 2017

Jun 21, 2018

BUY
$33.26 - $35.29 $7.38 Million - $7.83 Million
221,864
221,864 $8.04 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $162B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Greenline Partners, LLC Portfolio

Follow Greenline Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenline Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenline Partners, LLC with notifications on news.